Sabra Health Care REIT (NASDAQ:SBRA) Posts Quarterly Earnings Results, Hits Estimates

Sabra Health Care REIT (NASDAQ:SBRA) posted its quarterly earnings results on Wednesday. The real estate investment trust reported $0.36 earnings per share for the quarter, hitting the consensus estimate of $0.36, Zacks reports. The company had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a return on equity of 4.59% and a net margin of 18.02%. Sabra Health Care REIT updated its FY 2025 guidance to 1.430-1.460 EPS.

Sabra Health Care REIT Stock Performance

Shares of SBRA opened at $16.39 on Friday. The company has a market cap of $3.88 billion, a PE ratio of 30.93, a price-to-earnings-growth ratio of 1.99 and a beta of 1.25. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. The stock has a 50-day moving average price of $16.88 and a 200-day moving average price of $17.62. Sabra Health Care REIT has a 12-month low of $13.31 and a 12-month high of $20.03.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.32%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 226.42%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SBRA. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a research note on Tuesday, January 7th. Mizuho restated a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Truist Financial downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating and cut their target price for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Finally, Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.